Africa could have COVID-19 vaccine in Q1 if human trials work - S.Africa trial lead - (Fidelity via NewsPoints Desk)

  • Shabir Madhi, who is leading the South African vaccine trial, said that Africa could have a COVID-19 vaccine in the first quarter of 2021 if a clinical trial in South Africa succeeds, as reported Fidelity on Thursday.

  • The ChAdOx1 nCoV-19 experimental vaccine is also being tested in Brazil by Oxford University scientists who is working with AstraZeneca.

  • "A vaccine could be made commercial as early as the beginning of next year," Madhi said, "but it is completely dependent on the results of clinical trials."

  • Madhi noted that early results could be seen by November or December.

  • "The timing of an efficacy read-out depends on when we have around 42 COVID-19 cases at least one month after vaccination," he said.

To read more NewsPoints articles, click here.